Mr. Joe Ramos Iii, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 622 N Pearl St, Forrest, IL 61741 Phone: 779-237-0429 |
News Archive
Proton radiography imaging used prior to and during proton treatments for pediatric cancer patients provides for more accurate treatment delivery and a lower dose of radiation compared to standard diagnostic X-rays and cone beam CT, according to a study presented today at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
Two proteins that bind to stress hormones work together to maintain a healthy heart in mice, according to scientists at the National Institutes of Health and their collaborators.
Women who took beta carotene or vitamin C or E or a combination of the supplements had a similar risk of cancer as women who did not take the supplements, according to data from a randomized controlled trial in the December 30 online issue of the Journal of the National Cancer Institute.
Continucare Corporation announced today that its Board of Directors has approved the listing of the Company's common stock on the New York Stock Exchange (NYSE). Subject to the Company's continued compliance with the NYSE's initial listing standards, the Company expects to begin trading on the NYSE on or about November 1, 2010 under its current stock symbol "CNU."
The widely used cancer drug bevacizumab may cause severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The results suggest that physicians should monitor patients' kidney health when prescribing this angiogenesis inhibitor.
› Verified 4 days ago